{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:05:34Z","timestamp":1792638334546,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hepatocellular carcinoma (HCC) is a highly aggressive malignancy with a poor prognosis, primarily owing to its capacity of metastasis, underscoring the urgent need to identify novel drivers of HCC progression. While neurotransmitter receptors are increasingly recognized as regulators of tumor biology, the role of the gamma-aminobutyric acid type A receptor delta subunit (GABRD) in HCC remains unexplored. Here, we show that GABRD is significantly upregulated in HCC tissues and cell lines, and high expression of GABRD correlates with poor prognosis in HCC patients. Loss- and gain-of-function studies demonstrated that GABRD promotes HCC cell proliferation, invasion, and migration in vitro, and accelerates tumor growth in both subcutaneous xenograft and spontaneous HCC models in vivo. Mechanistically, we find that GABRD physically interacts with the interleukin-10 receptor alpha subunit (IL-10RA). This interaction orchestrates the activation of the JAK2-STAT3 signaling axis, driving epithelial-mesenchymal transition (EMT). Inhibition of JAK2-STAT3 and IL-10RA partially reverses the tumorigenic effects of GABRD. Our study establishes the GABRD-IL-10RA-JAK2-STAT3 axis as a critical oncogenic driver in HCC and identifies GABRD as a promising therapeutic target for improving HCC outcomes.<\/jats:p>","DOI":"10.1038\/s41419-026-08969-7","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T19:06:19Z","timestamp":1780945579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["GABRD promotes hepatocellular carcinoma progression via the IL-10RA\/JAK2-STAT3 signaling axis"],"prefix":"10.1038","volume":"17","author":[{"given":"Chengcheng","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2210-4340","authenticated-orcid":false,"given":"Chaoqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7930-1267","authenticated-orcid":false,"given":"Lu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4229-8153","authenticated-orcid":false,"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"key":"8969_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"8969_CR2","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1097\/JS9.0000000000001202","volume":"110","author":"T He","year":"2024","unstructured":"He T, Zou J, Sun K, Yang J. Global research status and frontiers on autophagy in hepatocellular carcinoma: a comprehensive bibliometric and visualized analysis. Int J Surg. 2024;110:2788\u2013802.","journal-title":"Int J Surg"},{"key":"8969_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology. 2021;73:4\u201313.","journal-title":"Hepatology"},{"key":"8969_CR4","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s41586-025-08634-7","volume":"641","author":"Y Sun","year":"2025","unstructured":"Sun Y, Wang X, Zhang DY, Zhang Z, Bhattarai JP, Wang Y, et al. Brain-wide neuronal circuit connectome of human glioblastoma. Nature. 2025;641:222\u201331.","journal-title":"Nature"},{"key":"8969_CR5","doi-asserted-by":"publisher","DOI":"10.1172\/JCI183544","volume":"135","author":"K Liu","year":"2025","unstructured":"Liu K, Zhang Y, Du G, Chen X, Xiao L, Jiang L, et al. 5-HT orchestrates histone serotonylation and citrullination to drive neutrophil extracellular traps and liver metastasis. J Clin Invest. 2025;135:e183544.","journal-title":"J Clin Invest"},{"key":"8969_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02219-0","volume":"24","author":"Q Huang","year":"2025","unstructured":"Huang Q, Hu B, Zhang P, Yuan Y, Yue S, Chen X, et al. Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment. Mol Cancer. 2025;24:24.","journal-title":"Mol Cancer"},{"key":"8969_CR7","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-17-0546","volume":"77","author":"MJ Bucsek","year":"2017","unstructured":"Bucsek MJ, Qiao G, MacDonald CR, Giridharan T, Evans L, Niedzwecki B, et al. \u03b2-adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8(+) T cells and undermines checkpoint inhibitor therapy. Cancer Res. 2017;77:5639\u201351.","journal-title":"Cancer Res"},{"key":"8969_CR8","doi-asserted-by":"publisher","first-page":"596","DOI":"10.3390\/ijms24010596","volume":"24","author":"N Kuol","year":"2022","unstructured":"Kuol N, Davidson M, Karakkat J, Filippone RT, Veale M, Luwor R, et al. Blocking muscarinic receptor 3 attenuates tumor growth and decreases immunosuppressive and cholinergic markers in an orthotopic mouse model of colorectal cancer. Int J Mol Sci. 2022;24:596.","journal-title":"Int J Mol Sci"},{"key":"8969_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.111217","volume":"126","author":"Y Dong","year":"2024","unstructured":"Dong Y, Wang G, Nie D, Xu Y, Bai X, Lu C, et al. Tumor-derived GABA promotes lung cancer progression by influencing TAMs polarization and neovascularization. Int Immunopharmacol. 2024;126:111217.","journal-title":"Int Immunopharmacol"},{"key":"8969_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115800","volume":"168","author":"X Qian","year":"2023","unstructured":"Qian X, Zhao X, Yu L, Yin Y, Zhang XD, Wang L, et al. Current status of GABA receptor subtypes in analgesia. Biomed Pharmacother. 2023;168:115800.","journal-title":"Biomed Pharmacother"},{"key":"8969_CR11","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1093\/brain\/awab391","volume":"145","author":"PK Ahring","year":"2022","unstructured":"Ahring PK, Liao VWY, Gardella E, Johannesen KM, Krey I, Selmer KK, et al. Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy. Brain. 2022;145:1299\u2013309.","journal-title":"Brain"},{"key":"8969_CR12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2400339121","volume":"121","author":"D Granados-Fuentes","year":"2024","unstructured":"Granados-Fuentes D, Lambert P, Simon T, Mennerick S, Herzog ED. GABA(A) receptor subunit composition regulates circadian rhythms in rest-wake and synchrony among cells in the suprachiasmatic nucleus. Proc Natl Acad Sci USA. 2024;121:e2400339121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8969_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40478-024-01727-w","volume":"12","author":"Z Guo","year":"2024","unstructured":"Guo Z, Tian C, Shi Y, Song XR, Yin W, Tao QQ, et al. Blood-based CNS regionally and neuronally enriched extracellular vesicles carrying pTau217 for Alzheimer\u2019s disease diagnosis and differential diagnosis. Acta Neuropathol Commun. 2024;12:38.","journal-title":"Acta Neuropathol Commun"},{"key":"8969_CR14","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.tips.2023.06.009","volume":"44","author":"B Luscher","year":"2023","unstructured":"Luscher B, Maguire JL, Rudolph U, Sibille E. GABA(A) receptors as targets for treating affective and cognitive symptoms of depression. Trends Pharmacol Sci. 2023;44:586\u2013600.","journal-title":"Trends Pharmacol Sci"},{"key":"8969_CR15","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41416-024-02761-0","volume":"131","author":"BB Lin","year":"2024","unstructured":"Lin BB, Huang Q, Yan B, Liu M, Zhang Z, Lei H, et al. An 18-gene signature of recurrence-associated endothelial cells predicts tumor progression and castration resistance in prostate cancer. Br J Cancer. 2024;131:870\u201382.","journal-title":"Br J Cancer"},{"key":"8969_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02593-z","volume":"22","author":"Y Yuan","year":"2022","unstructured":"Yuan Y, Ping W, Zhang R, Hao Z, Zhang N. DEPDC1B collaborates with GABRD to regulate ESCC progression. Cancer Cell Int. 2022;22:214.","journal-title":"Cancer Cell Int"},{"key":"8969_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70485","volume":"29","author":"W Leng","year":"2025","unstructured":"Leng W, Ye J, Wen Z, Wang H, Zhu Z, Song X, et al. GABRD accelerates tumour progression via regulating CCND1 signalling pathway in gastric cancer. J Cell Mol Med. 2025;29:e70485.","journal-title":"J Cell Mol Med"},{"key":"8969_CR18","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.7150\/thno.80544","volume":"13","author":"N Li","year":"2023","unstructured":"Li N, Xu X, Liu D, Gao J, Gao Y, Wu X, et al. The delta subunit of the GABA(A) receptor is necessary for the GPT2-promoted breast cancer metastasis. Theranostics. 2023;13:1355\u201369.","journal-title":"Theranostics"},{"key":"8969_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100861","volume":"13","author":"M Wu","year":"2020","unstructured":"Wu M, Kim KY, Park WC, Ryu HS, Choi SC, Kim MS, et al. Enhanced expression of GABRD predicts poor prognosis in patients with colon adenocarcinoma. Transl Oncol. 2020;13:100861.","journal-title":"Transl Oncol"},{"key":"8969_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1202193","volume":"11","author":"L Zhang","year":"2023","unstructured":"Zhang L, Deng Y, Yang J, Deng W, Li L. Neurotransmitter receptor-related gene signature as potential prognostic and therapeutic biomarkers in colorectal cancer. Front Cell Dev Biol. 2023;11:1202193.","journal-title":"Front Cell Dev Biol"},{"key":"8969_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/8709458","volume":"2023","author":"F Huang","year":"2023","unstructured":"Huang F, Wang Z, Zhu L, Lin C, Wang JX. Comprehensive analysis of the expression, prognostic value, and immune infiltration activities of GABRD in colon adenocarcinoma. Mediators Inflamm. 2023;2023:8709458.","journal-title":"Mediators Inflamm"},{"key":"8969_CR22","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3892\/ijo.2014.2310","volume":"44","author":"RY Liu","year":"2014","unstructured":"Liu RY, Zeng Y, Lei Z, Wang L, Yang H, Liu Z, et al. JAK\/STAT3 signaling is required for TGF-\u03b2-induced epithelial-mesenchymal transition in lung cancer cells. Int J Oncol. 2014;44:1643\u201351.","journal-title":"Int J Oncol"},{"key":"8969_CR23","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.drudis.2020.11.032","volume":"26","author":"PC Shih","year":"2021","unstructured":"Shih PC, Mei KC. Role of STAT3 signaling transduction pathways in cancer stem cell-associated chemoresistance. Drug Discov Today. 2021;26:1450\u20138.","journal-title":"Drug Discov Today"},{"key":"8969_CR24","doi-asserted-by":"publisher","DOI":"10.1172\/JCI167053","volume":"133","author":"AC Fan","year":"2023","unstructured":"Fan AC, Nakauchi Y, Bai L, Azizi A, Nuno KA, Zhao F, et al. RUNX1 loss renders hematopoietic and leukemic cells dependent on IL-3 and sensitive to JAK inhibition. J Clin Invest. 2023;133:e167053.","journal-title":"J Clin Invest"},{"key":"8969_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51496-2","volume":"15","author":"J Holzgruber","year":"2024","unstructured":"Holzgruber J, Martins C, Kulcsar Z, Duplaine A, Rasbach E, Migayron L, et al. Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade. Nat Commun. 2024;15:7165.","journal-title":"Nat Commun"},{"key":"8969_CR26","doi-asserted-by":"publisher","first-page":"a028548","DOI":"10.1101\/cshperspect.a028548","volume":"11","author":"X Wang","year":"2019","unstructured":"Wang X, Wong K, Ouyang W, Rutz S. Targeting IL-10 family cytokines for the treatment of human diseases. Cold Spring Harb Perspect Biol. 2019;11:a028548.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"8969_CR27","doi-asserted-by":"publisher","first-page":"e008491","DOI":"10.1136\/jitc-2023-008491","volume":"12","author":"Z Sun","year":"2024","unstructured":"Sun Z, Xu Y, Shao B, Dang P, Hu S, Sun H, et al. Exosomal circPOLQ promotes macrophage M2 polarization via activating IL-10\/STAT3 axis in a colorectal cancer model. J Immunother Cancer. 2024;12:e008491.","journal-title":"J Immunother Cancer"},{"key":"8969_CR28","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.ajpath.2013.12.002","volume":"184","author":"X Chen","year":"2014","unstructured":"Chen X, Calvisi DF. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Am J Pathol. 2014;184:912\u201323.","journal-title":"Am J Pathol"},{"key":"8969_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jhep.2024.12.037","volume":"83","author":"Y Sun","year":"2025","unstructured":"Sun Y, Xu M, Wan HL, Ding X, Wong AM, Pu D, et al. Spliced exon9 ADRM1 promotes liver oncogenicity via selective degradation of tumor suppressor FBXW7. J Hepatol. 2025;83:92\u2013104.","journal-title":"J Hepatol"},{"key":"8969_CR30","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/s43018-023-00624-w","volume":"4","author":"C Zheng","year":"2023","unstructured":"Zheng C, Snow BE, Elia AJ, Nechanitzky R, Dominguez-Brauer C, Liu S, et al. Tumor-specific cholinergic CD4(+) T lymphocytes guide immunosurveillance of hepatocellular carcinoma. Nat Cancer. 2023;4:1437\u201354.","journal-title":"Nat Cancer"},{"key":"8969_CR31","doi-asserted-by":"publisher","first-page":"3582","DOI":"10.1016\/j.neuron.2025.08.005","volume":"113","author":"C Anastasaki","year":"2025","unstructured":"Anastasaki C, Mu R, Kernan CM, Li X, Barakat R, Koleske JP, et al. Aberrant coupling of glutamate and tyrosine kinase receptors enables neuronal control of brain-tumor growth. Neuron. 2025;113:3582\u2013600.e7.","journal-title":"Neuron"},{"key":"8969_CR32","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jare.2020.08.005","volume":"28","author":"WL Dai","year":"2021","unstructured":"Dai WL, Bao YN, Fan JF, Ma B, Li SS, Zhao WL, et al. Blockade of spinal dopamine D1\/D2 receptor suppresses activation of NMDA receptor through G\u03b1q and Src kinase to attenuate chronic bone cancer pain. J Adv Res. 2021;28:139\u201348.","journal-title":"J Adv Res"},{"key":"8969_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216925","volume":"593","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Liu D, Guo D, Lin W, Lu W, Hu L, et al. CPSF3 regulates alternative polyadenylation of CNIH2 to promote esophageal squamous cell carcinoma progression. Cancer Lett. 2024;593:216925.","journal-title":"Cancer Lett"},{"key":"8969_CR34","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1016\/j.ccell.2025.09.003","volume":"43","author":"L Ren","year":"2025","unstructured":"Ren L, Liu C, \u00c7ifciba\u015f\u0131 K, Ballmann M, Rammes G, Mota Reyes C, et al. Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses. Cancer Cell. 2025;43:2241\u201358.e8.","journal-title":"Cancer Cell"},{"key":"8969_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/md23100389","volume":"23","author":"IE Kasheverov","year":"2025","unstructured":"Kasheverov IE, Shelukhina IV, Utkin YN, Tsetlin VI. Marine-derived ligands of nicotinic acetylcholine receptors in cancer research. Mar Drugs. 2025;23:389.","journal-title":"Mar Drugs"},{"key":"8969_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-025-02441-4","volume":"24","author":"C Zhang","year":"2025","unstructured":"Zhang C, Guo X, Wang Y, Zhang S, Wang Z. The role of acetylcholine and its receptors in tumor immune regulation: mechanisms and potential therapeutic targets. Mol Cancer. 2025;24:231.","journal-title":"Mol Cancer"},{"key":"8969_CR37","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/s41556-021-00820-9","volume":"24","author":"D Huang","year":"2022","unstructured":"Huang D, Wang Y, Thompson JW, Yin T, Alexander PB, Qin D, et al. Cancer-cell-derived GABA promotes \u03b2-catenin-mediated tumour growth and immunosuppression. Nat Cell Biol. 2022;24:230\u201341.","journal-title":"Nat Cell Biol"},{"key":"8969_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41586-021-04082-1","volume":"599","author":"B Zhang","year":"2021","unstructured":"Zhang B, Vogelzang A, Miyajima M, Sugiura Y, Wu Y, Chamoto K, et al. B cell-derived GABA elicits IL-10(+) macrophages to limit anti-tumour immunity. Nature. 2021;599:471\u20136.","journal-title":"Nature"},{"key":"8969_CR39","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1016\/j.cell.2025.02.002","volume":"188","author":"Z Chang","year":"2025","unstructured":"Chang Z, Guo X, Li X, Wang Y, Zang Z, Pei S, et al. Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization. Cell. 2025;188:1842\u201357.e20.","journal-title":"Cell"},{"key":"8969_CR40","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jhep.2023.12.015","volume":"80","author":"AM Shiri","year":"2024","unstructured":"Shiri AM, Zhang T, Bedke T, Zazara DE, Zhao L, L\u00fccke J, et al. IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction. J Hepatol. 2024;80:634\u201344.","journal-title":"J Hepatol"},{"key":"8969_CR41","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1182\/blood.2024025755","volume":"145","author":"M Garcia-Lacarte","year":"2025","unstructured":"Garcia-Lacarte M, Grijalba SC, Melchor J, Pascual M, Go\u00f1i E, Clemente-Larramendi I, et al. IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapy. Blood. 2025;145:2746\u201361.","journal-title":"Blood"},{"key":"8969_CR42","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1136\/gutjnl-2018-317479","volume":"68","author":"SH Jiang","year":"2019","unstructured":"Jiang SH, Zhu LL, Zhang M, Li RK, Yang Q, Yan JY, et al. GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca(2+) signalling in a GABA-independent manner. Gut. 2019;68:1994\u20132006.","journal-title":"Gut"},{"key":"8969_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2025.102344","volume":"88","author":"W Du","year":"2025","unstructured":"Du W, Ouyang Y, Feng X, Yu C, Zhang H, Chen S, et al. IL-10RA promotes lung cancer cell proliferation by increasing fatty acid oxidation via STAT3 signaling pathway. Pulm Pharmacol Ther. 2025;88:102344.","journal-title":"Pulm Pharmacol Ther"},{"key":"8969_CR44","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1038\/s41375-024-02391-8","volume":"38","author":"J Sun","year":"2024","unstructured":"Sun J, Corradini S, Azab F, Shokeen M, Muz B, Miari KE, et al. IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma. Leukemia. 2024;38:2355\u201365.","journal-title":"Leukemia"},{"key":"8969_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41392-022-01300-8","volume":"8","author":"F Shu","year":"2023","unstructured":"Shu F, Xiao H, Li QN, Ren XS, Liu ZG, Hu BW, et al. Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets. Signal Transduct Target Ther. 2023;8:32.","journal-title":"Signal Transduct Target Ther"},{"key":"8969_CR46","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.124.012180","volume":"18","author":"N Yang","year":"2025","unstructured":"Yang N, Li L, Shi XL, Liu YP, Wen R, Yang YH, et al. Succinylation of SERCA2a at K352 promotes its ubiquitinoylation and degradation by proteasomes in sepsis-induced heart dysfunction. Circ Heart Fail. 2025;18:e012180.","journal-title":"Circ Heart Fail"},{"key":"8969_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35795-8","volume":"14","author":"JM Lee","year":"2023","unstructured":"Lee JM, Hammar\u00e9n HM, Savitski MM, Baek SH. Control of protein stability by post-translational modifications. Nat Commun. 2023;14:201.","journal-title":"Nat Commun"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08969-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08969-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08969-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:01:36Z","timestamp":1786629696000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-026-08969-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8969"],"URL":"https:\/\/doi.org\/10.1038\/s41419-026-08969-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"11 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods in this study were performed in accordance with the relevant guidelines and regulations. The research involving human participants adhered to the ethical guidelines outlined in the Declaration of Helsinki. The collection of samples was approved by the Medical Ethics Committee of the Second Affiliated Hospital of Army Medical University, PLA. Informed consent was obtained from all participants before enrollment. The animal experiments were accomplished in compliance with ethical standards. All animal experiments were performed with the approval of the Laboratory Animal Welfare and Ethics Committee of Third Military Medical University, according to the Chinese Guidelines on the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"720"}}